Skip to content
Screener

Investments And Cash at other companies

Arcus Biosciences logo
Arcus BiosciencesRCUS
$775M-16.4%
American Financial Group logo
American Financial GroupAFG
$17.07B+6.4%
Ardelyx logo
ArdelyxARDX
$281.83M+18.2%
Globe Life logo
Globe LifeGL
$20.66B+2.1%
Globe Life logo
Globe LifeGL
$0
Globe Life logo
Globe LifeGL
$0

Other financials

Income statement

See full
Revenue$176.2M+37.9%
Operating income-$42.5M-753%
Net income-$67.2M-1,047%
EPS (diluted)-$1.06-783%

Balance sheet

See full
Cash & equivalents$262.7M+39.4%
Total debt$12.9M+29.2%
Total equity-$10.4M-104%
Total assets$1.0B+44.0%

Cash flow

See full
Operating cash flow-$44.3M-468%
CapEx$23.0K-81.7%
Free cash flow-$44.3M-472%

Valuation

See full
Market cap$6.45B+144%
Enterprise value$6.2B+151%
P/S10.4×+4.3×

Profitability

See full
Operating margin-134.9%-151pp
Net margin-139.2%-156pp
FCF margin-37%

Returns & leverage

See full
Return on equity-335.8%-377pp
Debt / equity0.1×0.0×
Current ratio2.9×-0.3×

Where this comes from

Reported directly by Mirum Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:InvestmentsAndCash.

The source filing: Mirum Pharmaceuticals, Inc.’s 10-Q, filed August 5, 2026. Open the filing →

Filed
Aug 5, 2026, 4:06 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001759425-26-000045

FAQ

What is Mirum Pharmaceuticals, Inc.'s investments and cash?
Mirum Pharmaceuticals, Inc. (MIRM) reported investments and cash of $561.3M in Q2 2026.
How has Mirum Pharmaceuticals, Inc.'s investments and cash changed year-over-year?
Mirum Pharmaceuticals, Inc.'s investments and cash increased by 74.5% year-over-year, from $321.7M to $561.3M.
What does investments and cash mean?
Investments And Cash as reported by Mirum Pharmaceuticals, Inc. Common Stock.

Ask your AI about Mirum Pharmaceuticals, Inc.'s investments and cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude